Back to search

Switzerland· 53371027

Zoladex LA SafeSystem, Fertigspritze mit Implantat

A goserelin product containing goserelinum, registered in Switzerland by AstraZeneca AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC L02AE03

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedZoladex LA SafeSystem, Fertigspritze …ATCL02AE03REGISTER NO.53371027PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Goserelin is registered in 12 of 19 countries.

Countries holding a registration under ATC L02AE03 (goserelin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Goserelin · ATC L02AE03

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of goserelin costs, country by country.

Normalised to the WHO defined daily dose (0.129 mg), so markets compare like for like.

  • Switzerland: $5.39 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Goserelin · price per daily dose (0.129 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$5.39
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
goserelinum
Manufacturer
AstraZeneca AG
Country
Switzerland (CH)
ATC code
L02AE03
ATC class
Goserelin
Defined daily dose
0.129 mg, Implantat
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680533710275
    Fertspr 1 Stk
    CHF 369.15

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

461 interactions on record for goserelin.

Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Goserelin · interactions on record

461 records

  • 71 severe
  • 250 moderate
  • 3 minor
  • 137 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Goserelin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All goserelin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Zoladex Depot
  • Belgium · Zoladex, Zoladex Long Acting
  • Bulgaria · Золадекс, Золадекс Lа
  • Cyprus · Zoladex
  • Czechia · Reseligo, Zoladex Depot
  • Germany · Goserelin Endomedica, Gosgon
  • Denmark · Zoladex
  • Estonia · Reseligo, Zoladex
  • Spain · Zoladex, Zoladex Trimestral
  • Finland · Zoladex
  • France · Zoladex
  • United Kingdom (Northern Ireland) · Zoladex, Zoladex La
  • Greece · Implandex, Implandex La
  • Croatia · Reseligo, Zoladex
  • Hungary · Reseligo, Zildalis
  • Ireland · Zoladex, Zoladex La
  • Iceland · Reseligo, Zoladex
  • Italy · Zoladex
  • Lithuania · Algonad, Reseligo
  • Luxembourg · Zoladex, Zoladex Long Acting
  • Latvia · Reseligo
  • Malta · Golexin, Golexin La
  • Netherlands · Zoladex
  • Norway · Zoladex
  • Poland · Reseligo, Xanderla
  • Portugal · Golexin, Golexin La
  • Romania · Reseligo, Zoladex
  • Sweden · Zoladex
  • Slovenia · Reseligo, Zoladex
  • Slovakia · Reseligo, Zoladex Depot

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/be0fcb7c-b81b-4fd5-9896-de78f23310e8
GET /v1/drugs/be0fcb7c-b81b-4fd5-9896-de78f23310e8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "goserelinum 10.8 mg",
  "valid_from": "1996-03-15",
  "limitations": null,
  "galenic_form": "Implant 10.8 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "1996-03-15",
  "self_retention_pct": 10
}

See everything about goserelin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.